NCT00459004View on ClinicalTrials.gov

Japanese Dose-Response Study of Rimonabant in Obese Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

527

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Obesity

Interventions

DRUG

rimonabant (SR141716)

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY